Application of 4044-58-0, These common heterocyclic compound, 4044-58-0, name is 1-Bromo-8-iodonaphthalene, its traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route.
A mixture of Cul (1.57 g, 8.26 mmol, 1.1 eq) and KF (479 mg, 8.26 mmol, 193 pL, 1.1 eq) was thoroughly mixed and heated to 150 C under vacuum by using oil pump with heat gun with gentle shaking until an homogemeous greenish color was obtained. To the mixture was added DMSO (50 mL), trimethyl(trifluoromethyl)silane (3.20 g, 22.5 mmol, 3.0 eq) and l-bromo-8-iodo-naphthalene (2.5 g, 7.51 mmol, 1.0 eq) was added and the slurry was heated to 25 C for 16 h. The reaction mixture was diluted with ethyl acetate (50 mL) and washed with water (3 c 30 mL). The combined organic layers were washed with brine (20 mL), dried over Na2S04, filtered and concentrated under reduced pressure to give a residue. The residue was purified by prep-HPLC (column: Phenomenex Synergi C18 150*25* lOpm; mobile phase: [water (0.225% FA) – ACN]; B%: 66%- 86%, lOmin). l-bromo-8- (trifluoromethyl)naphthalene (900 mg, 3.14 mmol, 42% yield, 96% purity) was obtained as a white solid. (0758) [0436] *H NMR (400MHz, chloroform-d) d = 8.12 (d, J= 7.6 Hz, 1H), 8.10 – 8.02 (m, 2H), 7.90 (dd, J = 1.2, 8.0 Hz, 1H), 7.54 (t, J= 7.6 Hz, 1H), 7.37 (t, .7= 7.6 Hz, 1H).
Statistics shows that 1-Bromo-8-iodonaphthalene is playing an increasingly important role. we look forward to future research findings about 4044-58-0.
Reference:
Patent; MIRATI THERAPEUTICS, INC.; ARRAY BIOPHARMA, INC.; MARX, Matthew, Arnold; BLAKE, James, F.; FELL, Jay, Bradford; FISCHER, John, P.; MEJIA, Macedonio, J.; (164 pag.)WO2020/47192; (2020); A1;,
Iodide – Wikipedia,
Iodide – an overview | ScienceDirect Topics – ScienceDirect.com